DISCONTINUED OPERATIONS

6 Months Ended

Jun. 30, 2014

Discontinued Operations [Abstract]

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS

Results of operations for OralDNA, HemoCue and NID have been reported as discontinued operations for the three and six months ended June 30, 2014 and 2013.

Discontinued operations, net of taxes, for the three and six months ended June 30, 2013 includes a gain of $13 million (including foreign currency translation adjustments, partially offset by income tax expense and transaction costs) associated with the sale of HemoCue. In addition, income from discontinued operations, net of taxes for the six months ended June 30, 2013, includes discrete tax benefits of $20 million associated with favorable resolution of certain tax contingencies related to the Company's NID business.

Summarized financial information for the discontinued operations is as follows:

	Three Months Ended June 30,					Six Months Ended June 30,
	2014		2013			2014		2013
Net revenues	$	—	$	3		$	—	$	28
Income from discontinued operations before taxes	—		21			—		22
Income tax (expense) benefit	—		(8		)	—		11
Income from discontinued operations, net of taxes	$	—	$	13		$	—	$	33

The remaining balance sheet information related to HemoCue, OralDNA and NID was not material at June 30, 2014 and December 31, 2013.